We are live on ! Find out more
PCM

Peregrine Capital Management Portfolio holdings

AUM $3.08B
1-Year Est. Return 29.51%
This Fund
S&P 500
This Quarter Est. Return
+9.23%
1 Year Est. Return
+29.51%
3 Year Est. Return
+95.04%
5 Year Est. Return
+107.83%
10 Year Est. Return
+715.34%
AUM
$3.77B
AUM Growth
+$253M
Cap. Flow
+$22.3M
Cap. Flow %
0.59%
Top 10 Hldgs %
14.53%
Holding
374
New
78
Increased
120
Reduced
113
Closed
25

Sector Composition

Rank Sector Weight
1 Technology 22.74%
2 Healthcare 21.63%
3 Financials 13.87%
4 Consumer Discretionary 12.67%
5 Industrials 12.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PINC
126
DELISTED
Premier
PINC
$10.9M 0.29%
332,642
+50,049
+18% +$1.66M
ABG icon
127
Asbury Automotive
ABG
$3.73B
$10.5M 0.28%
107,411
+16,400
+18% +$1.66M
PGTI
128
DELISTED
PGT, Inc.
PGTI
$10.4M 0.27%
591,896
-56,265
-9% -$987K
WWD icon
129
Woodward
WWD
$21.1B
$10.4M 0.27%
129,267
-12,255
-9% -$985K
TCMD icon
130
Tactile Systems Technology
TCMD
$547M
$10.3M 0.27%
281,705
-26,903
-9% -$985K
CCXI
131
DELISTED
ChemoCentryx, Inc.
CCXI
$10.3M 0.27%
+187,244
New +$10.1M
DY icon
132
Dycom Industries
DY
$12.1B
$10.1M 0.27%
190,929
-65,558
-26% -$3.18M
IRWD icon
133
Ironwood Pharmaceuticals
IRWD
$711M
$10M 0.27%
1,117,031
-106,247
-9% -$1.06M
FORM icon
134
FormFactor
FORM
$9.46B
$10M 0.27%
401,811
+2,327
+0.6% +$64.9K
MDRX
135
DELISTED
Veradigm Inc. Common Stock
MDRX
$9.88M 0.26%
1,213,892
-114,979
-9% -$939K
CERS icon
136
Cerus
CERS
$516M
$9.85M 0.26%
1,573,772
+134,565
+9% +$893K
OPLN
137
Openlane
OPLN
$4.48B
$9.81M 0.26%
680,938
+2,886
+0.4% +$45.1K
CHRS icon
138
Coherus Oncology
CHRS
$187M
$9.63M 0.26%
524,892
+79,635
+18% +$1.48M
LPRO
139
DELISTED
Open Lending Corp
LPRO
$9.59M 0.25%
375,928
-35,771
-9% -$697K
CCS icon
140
Century Communities
CCS
$2.01B
$9.52M 0.25%
224,789
+34,222
+18% +$1.25M
WCC
141
WESCO International
WCC
$17.8B
$9.38M 0.25%
213,102
+31,897
+18% +$1.36M
MDC
142
DELISTED
M.D.C. Holdings, Inc.
MDC
$9.28M 0.25%
212,750
+32,483
+18% +$1.3M
TPC
143
Tutor Perini Cor
TPC
$5.13B
$9.18M 0.24%
824,963
+124,915
+18% +$1.53M
GMS
144
DELISTED
GMS Inc
GMS
$8.88M 0.24%
368,296
+55,700
+18% +$1.36M
CLDR
145
DELISTED
Cloudera, Inc.
CLDR
$8.86M 0.23%
813,603
+69,570
+9% +$807K
TRHC
146
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
$8.78M 0.23%
215,289
-20,598
-9% -$1.03M
TXNM
147
TXNM Energy Inc
TXNM
$5.91B
$8.74M 0.23%
211,513
+31,944
+18% +$1.33M
DAR icon
148
Darling Ingredients
DAR
$9.84B
$8.65M 0.23%
240,057
+36,571
+18% +$1.12M
TPTX
149
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
$8.65M 0.23%
+99,001
New +$6.9M
ZYME icon
150
Zymeworks
ZYME
$1.73B
$8.58M 0.23%
184,263
-18,303
-9% -$628K

Similar funds

Peregrine Capital Management's Q3 2020 Portfolio in Review

As of Q3 2020, Peregrine Capital Management held 374 positions worth $3.77B, up 7.2% from $3.52B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Peregrine Capital Management's Q3 2020 filing shows 78 new, 120 increased, 113 reduced and 25 closed positions. Its largest new stake was Planet Fitness: 504,064 shares worth $31.1M. The largest sale was Illumina, an estimated $34M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 24% a quarter earlier, followed by Healthcare and Financials.

  • Peregrine Capital Management's largest Q3 2020 buy was Planet Fitness: 504,064 shares worth $31.1M.
  • Peregrine Capital Management added most to Pinnacle Financial Partners Inc in Q3 2020, an estimated $7.7M increase.
  • Peregrine Capital Management's biggest Q3 2020 reduction was Teladoc Health, cutting an estimated $19.8M.
  • Peregrine Capital Management fully exited Illumina in Q3 2020, selling an estimated $34M.
  • Peregrine Capital Management's ten largest holdings make up 15% of its $3.77B portfolio in Q3 2020.
  • Peregrine Capital Management opened 78 new positions and closed 25 in Q3 2020.
  • Peregrine Capital Management's portfolio value rose 7.2% quarter-over-quarter to $3.77B.

Based on Peregrine Capital Management's 13F filing for Q3 2020, filed 20 Oct 2020.